1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347(16):1233-1241.
2. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. The New England journal of medicine 2002, 347(16):1227-1232.
3. Hofvind S, Holen A, Aas T, Roman M, Sebuodegard S, Akslen LA: Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015, 41(10):1417-1422.
4. Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA: Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer 2013, 119(7):1402-1411.
5. Hennigs A, Hartmann B, Rauch G, Golatta M, Tabatabai P, Domschke C, Schott S, Schutz F, Sohn C, Heil J: Long-term objective esthetic outcome after breast-conserving therapy. Breast Cancer Res Treat 2015, 153(2):345-351.
6. Foersterling E, Golatta M, Hennigs A, Schulz S, Rauch G, Schott S, Domschke C, Schuetz F, Sohn C, Heil J: Predictors of early poor aesthetic outcome after breast-conserving surgery in patients with breast cancer: initial results of a prospective cohort study at a single institution. J Surg Oncol 2014, 110(7):801-806.
7. Volders JH, Negenborn VL, Haloua MH, Krekel NMA, Jozwiak K, Meijer S, van den Tol PM: Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study. J Surg Oncol 2018, 117(5):1001-1008.
8. Heil J, Holl S, Golatta M, Rauch G, Rom J, Marme F, Gebauer G, Sohn C: Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS). Breast 2010, 19(6):470-474.
9. Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK: Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol 2008, 26(20):3331-3337.
10. Horst KC, Smitt MC, Goffinet DR, Carlson RW: Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005, 5(6):425-438.
11. Funk A, Heil J, Harcos A, Gomez C, Stieber A, Junkermann H, Hennigs A, Rauch G, Sinn HP, Riedel F et al: Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery. Breast Cancer Res Treat 2020, 179(2):425-433.
12. Ciccarelli G, Di Virgilio MR, Menna S, Garretti L, Ala A, Giani R, Bussone R, Canavese G, Berardengo E: Radiography of the surgical specimen in early stage breast lesions: diagnostic reliability in the analysis of the resection margins. Radiol Med 2007, 112(3):366-376.
13. Chagpar AB, Butler M, Killelea BK, Horowitz NR, Stavris K, Lannin DR: Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study. Am J Surg 2015, 210(5):886-890.
14. von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J et al: Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012, 30(15):1796-1804.
15. Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, Golatta M, Liefers GJ, Vrancken Peeters MJ: Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol 2020, 31(1):61-71.
16. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms [http://www.awmf.org/uploads/tx_szleitlinien/032-045OL_k_S3__Brustkrebs_Mammakarzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf]
17. Fachgesellschaften AdWM: Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. 2017.
18. McCormick JT, Keleher AJ, Tikhomirov VB, Budway RJ, Caushaj PF: Analysis of the use of specimen mammography in breast conservation therapy. Am J Surg 2004, 188(4):433-436.
19. Hisada T, Sawaki M, Ishiguro J, Adachi Y, Kotani H, Yoshimura A, Hattori M, Yatabe Y, Iwata H: Impact of intraoperative specimen mammography on margins in breast-conserving surgery. Mol Clin Oncol 2016, 5(3):269-272.
20. Schmachtenberg C, Engelken F, Fischer T, Bick U, Poellinger A, Fallenberg EM: Intraoperative specimen radiography in patients with nonpalpable malignant breast lesions. Rofo 2012, 184(7):635-642.
21. Mazouni C, Rouzier R, Balleyguier C, Sideris L, Rochard F, Delaloge S, Marsiglia H, Mathieu MC, Spielman M, Garbay JR: Specimen radiography as predictor of resection margin status in non-palpable breast lesions. Clin Radiol 2006, 61(9):789-796.
22. Versteegden DPA, Keizer LGG, Schlooz-Vries MS, Duijm LEM, Wauters CAP, Strobbe LJA: Performance characteristics of specimen radiography for margin assessment for ductal carcinoma in situ: a systematic review. Breast Cancer Res Treat 2017.
23. Rua C, Lebas P, Michenet P, Ouldamer L: Evaluation of lumpectomy surgical specimen radiographs in subclinical, in situ and invasive breast cancer, and factors predicting positive margins. Diagn Interv Imaging 2012, 93(11):871-877.
24. Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML: Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ. J Surg Oncol 2018, 118(7):1205-1211.
25. Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML: Intraoperative Margin Assessment in Wire-Localized Breast-Conserving Surgery for Invasive Cancer: A Population-Level Comparison of Techniques. Annals of surgical oncology 2016, 23(10):3290-3296.
26. Gray RJ, Pockaj BA, Garvey E, Blair S: Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature. Annals of surgical oncology 2017.
27. Heil J, Pfob A: Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'. Ann Oncol 2020, 31(9):1264.
28. Dahlback C, Manjer J, Rehn M, Ringberg A: Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery. World J Surg Oncol 2016, 14(1):303.
29. Cochrane RA, Valasiadou P, Wilson AR, Al-Ghazal SK, Macmillan RD: Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg 2003, 90(12):1505-1509.
30. Clingan R, Griffin M, Phillips J, Coberly W, Jennings W: Potential margin distortion in breast tissue by specimen mammography. Arch Surg 2003, 138(12):1371-1374.
31. Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD: Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 1996, 198(2):327-332.
32. Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE: Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 1993, 47(5):339-344.
33. Goorts B, van Nijnatten TJ, de Munck L, Moossdorff M, Heuts EM, de Boer M, Lobbes MB, Smidt ML: Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat 2017, 163(1):83-91.
34. Kagihara JA, Andress M, Diamond JR: Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions. Expert Rev Precis Med Drug Dev 2020, 5(2):59-65.
35. Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, Hennigs A, Richter H, Domschke C, Schuetz F et al: Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response? Ann Surg Oncol 2016, 23(3):789-795.
36. Pfob A, Sidey-Gibbons C, Lee HB, Tasoulis MK, Koelbel V, Golatta M, Rauch GM, Smith BD, Valero V, Han W et al: Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy. Eur J Cancer 2021, 143:134-146.
37. Molina MA, Snell S, Franceschi D, Jorda M, Gomez C, Moffat FL, Powell J, Avisar E: Breast specimen orientation. Ann Surg Oncol 2009, 16(2):285-288.